Telecom Italia-backed growth-stage investment vehicle UV T-Growth is over halfway towards an upsized fundraising target.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Amazon-backed food delivery service raised $2.07bn in its initial public offering only to see its shares fall some 25% on its opening day.

Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.

The recently launched venture firm has secured capital commitments to its debut fund from investors including Axa and MACSF.

Satt Paris-Saclay’s portfolio company Altaroad has raised $11.7m in funding.

UK-based biopharmaceutical company raises $75m in IPO

Q&A with Cristina Moyano de Navascués, investment manager, Amadeus Ventures

The vertical take-off and landing jet developer, an Unternehmertum spinout, is joining forces with the Nasdaq-listed Qell Acquisition Corp.

Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.